Trifluridine and Tipiracil Hydrochloride Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 733030-01-8, Lonsurf, TAS 102, TAS 102,, TAS-102, Thymidine, Tipiracil Hydrochlorid Mixture with Trifluridine, Tipiracil Hydrochloride Mixture with Trifluridine, Trifluridine/Tipiracil, Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102

Filter by location:

Birmingham, Alabama1 trial

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

University of Alabama at Birmingham Cancer Center

Phase 2

Buffalo, New York1 trial

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Roswell Park Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.